Creative Medical Tech Stock (NASDAQ: CELZ) stock price, news, charts, stock research, profile.
You can purchase shares of Creative Medical Tech (NASDAQ:CELZ) through any online brokerage.
Other companies in Creative Medical Tech’s space includes: Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Protagenic Therapeutics (NASDAQ:PTIX).
Creative Medical Tech has a consensus price target of $10.00.
The stock price for Creative Medical Tech (NASDAQ: CELZ) is $2.4 last updated December 16, 2024 at 7:49 PM EST.
There are no upcoming dividends for Creative Medical Tech.
Creative Medical Tech’s Q4 earnings are confirmed for Friday, March 21, 2025.
There is no upcoming split for Creative Medical Tech.
Creative Medical Tech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.